Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Documenti analoghi

• The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod
  di: Patmanathan, S.N., et al.
  Pubblicazione: (2015)
• Investigation of immune and CNS-mediated effects of fingolimod in the focal delayed-type hypersensitivity multiple sclerosis model.
  di: Anthony, D, et al.
  Pubblicazione: (2014)
• Ameliorative effects of Fingolimod (FTY720) on microglial activation and psychosis-related behavior in short term cuprizone exposed mice
  di: Siyao Li, et al.
  Pubblicazione: (2023-07-01)
• The Immunosuppressant Fingolimod (FTY720) for the Treatment of Mechanical Force-Induced Abnormal Scars
  di: Masayo Aoki, et al.
  Pubblicazione: (2020-01-01)
• Fingolimod (FTY720) stimulates Ca(2+)/calcineurin signaling in fission yeast.
  di: Kanako Hagihara, et al.
  Pubblicazione: (2013-01-01)